Education
About Us
Working with TipRanks
Follow Us
Option Care Health Inc (OPCH)
:OPCH
OPCH Stock Chart & Stats
Day’s Range― - ―
52-Week Range$21.39 - $35.53
Previous CloseN/A
Volume256.90K
Average Volume (3M)1.76M
Market Cap
$4.53B
Enterprise Value$6.36B
Total Cash (Recent Filing)$198.82M
Total Debt (Recent Filing)$1.23B
Price to Earnings (P/E)22.8
Beta0.59
Next Earnings
Oct 30, 2025EPS Estimate
0.43Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.41
Shares Outstanding162,295,060
10 Day Avg. Volume2,040,223
30 Day Avg. Volume1,761,146
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market Cap1.40
Enterprise Value/Revenue1.18
Enterprise Value/Gross Profit6.02
Enterprise Value/Ebitda15.58
Forecast
1Y Price Target
$38.67Price Target Upside34.50% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering5
Bulls Say, Bears Say
Bulls Say
EarningsOption Care Health's revenue of $1.42 billion significantly outperformed estimates and demonstrated strong growth compared to the previous year, highlighting the company's ability to capture market share, especially in acute therapy.
Financial GuidanceFY/25 financial guidance was updated in a positive manner for the third time this year and now includes an expectation of $5.50-5.65 billion in revenue.
Investment RatingThe analyst maintains an OUTPERFORM investment rating on OPCH with a price target of $38, suggesting a significant upside potential for investors.
Bears Say
External RisksOption Care is potentially exposed to tariff risk through the drugs it utilizes in providing infusion services.
Gross MarginGross margin as a percentage came in slightly below expectations, although there was still an increase in gross margin dollars compared to the previous year.
Management ChangeThe departure of the long-serving CFO, Mike Shapiro, is unfortunate given his strong operational track record and consistent delivery of financial results ahead of expectations.
Option Care Health News
OPCH FAQ
What was Option Care Health Inc’s price range in the past 12 months?
Option Care Health Inc lowest stock price was $21.39 and its highest was $35.53 in the past 12 months.
What is Option Care Health Inc’s market cap?
Option Care Health Inc’s market cap is $4.53B.
When is Option Care Health Inc’s upcoming earnings report date?
Option Care Health Inc’s upcoming earnings report date is Oct 30, 2025 which is in 61 days.
How were Option Care Health Inc’s earnings last quarter?
Option Care Health Inc released its earnings results on Jul 30, 2025. The company reported $0.41 earnings per share for the quarter, beating the consensus estimate of $0.394 by $0.016.
Is Option Care Health Inc overvalued?
According to Wall Street analysts Option Care Health Inc’s price is currently Undervalued.
Does Option Care Health Inc pay dividends?
Option Care Health Inc does not currently pay dividends.
What is Option Care Health Inc’s EPS estimate?
Option Care Health Inc’s EPS estimate is 0.43.
How many shares outstanding does Option Care Health Inc have?
Option Care Health Inc has 162,295,060 shares outstanding.
What happened to Option Care Health Inc’s price movement after its last earnings report?
Option Care Health Inc reported an EPS of $0.41 in its last earnings report, beating expectations of $0.394. Following the earnings report the stock price went up 1.693%.
Which hedge fund is a major shareholder of Option Care Health Inc?
Currently, no hedge funds are holding shares in OPCH
Option Care Health Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$38.67 (34.50% Upside)
$38.67 (34.50% Upside)
Blogger Sentiment
Neutral
OPCH Sentiment 50%
Sector Average 70%
Sector Average 70%
Hedge Fund Trend
Increased
By 609.2K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Bought Shares
Worth $1.6M over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Positive
Last 7 Days ▲ 13.8%
Last 30 Days ▲ 9.9%
Last 30 Days ▲ 9.9%
News Sentiment
Neutral
Bullish news 59%
Bearish news 100%
Bearish news 100%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-8.52%
12-Months-Change
Fundamentals
Return on Equity
15.25%
Trailing 12-Months
Asset Growth
1.02%
Trailing 12-Months
Company Description
Option Care Health Inc
Option Care Health, Inc. offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including Crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders. It also offers treatments to manage the progression of neurological disorders, such as amyotrophic lateral sclerosis and duchenne muscular dystrophy; infusion therapies for bleeding disorders; therapies that women need to survive and thrive through high-risk pregnancies; and other infusion therapies to treat various conditions, including pain management, chemotherapy, and respiratory medications, as well as nursing services. Option Care Health, Inc. is headquartered in Bannockburn, Illinois.
OPCH Earnings Call
Q2 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
The earnings call reflected a strong overall performance by Option Care Health, with significant revenue growth, increased financial guidance, and cash flow generation. Although there were some challenges related to Stelara's discontinuation and gross margin pressure, these were overshadowed by the company's strategic initiatives and effective execution across its portfolio.View all OPCH earnings summariesOPCH Stock 12 Month Forecast
Average Price Target
$38.67
▲(34.50% Upside)
Technical Analysis
Ownership Overview
1.28% Insiders
37.99% Mutual Funds
24.20% Other Institutional Investors
11.15% Public Companies and
Individual Investors